Potassium chloride 0.15% (potassium 10mmol/500ml) / Glucose 4% / Sodium chloride 0.18% infusion 500ml bags

国家: 英国

语言: 英文

来源: MHRA (Medicines & Healthcare Products Regulatory Agency)

有效成分:

Potassium chloride; Glucose anhydrous; Sodium chloride

可用日期:

potassium 10mmol/500ml) / Glucose 4% / Sodium chloride 0.18% infusion 500ml bags (Baxter Healthcare Ltd

ATC代码:

B05BB02

INN（国际名称）:

Potassium chloride; Glucose anhydrous; Sodium chloride

剂量:

1.5mg/1ml ; 40mg/1ml ; 1.8mg/1ml

药物剂型:

Infusion

给药途径:

Intravenous

类:

No Controlled Drug Status

处方类型:

Valid as a prescribable product

產品總結:

BNF: 09020201

产品特点

OBJECT 1
POTASSIUM CHLORIDE 0.15 % W/V, SODIUM CHLORIDE
0.18 % W/V AND GLUCOSE 4% W/V, SOLUTION FOR
INFUSION
Summary of Product Characteristics Updated 01-Apr-2015 | Baxter
Healthcare Ltd
1. Name of the medicinal product
Potassium Chloride 0.15 % w/v, Sodium Chloride 0.18 % w/v and Glucose
4% w/v, Solution for
Infusion.
2. Qualitative and quantitative composition
Potassium Chloride
Sodium Chloride:
Glucose:
1.5 g/l
1.8 g/l
40.0 g/l
(equivalent to Glucose monohydrate 44 g/l)
mmol/l
mEq/l
K
+
20
20
Na
+
31
31
Cl
-
51
51
For the full list of excipients: see Section 6.1.
3. Pharmaceutical form
Solution for infusion.
Clear solution, free from visible particles.
4. Clinical particulars
4.1 Therapeutic indications
Prevention and treatment of potassium, sodium and chloride depletion
due to a loss of gastrointestinal
fluid (vomiting, diarrhoea, surgical drainage, gastric suction, small
intestinal bypass procedure, or small
bowel fistula), a chronic abuse of laxative, malabsorption syndromes,
mucus secreting villous adenoma of
the small intestine, or renal salt-losing conditions (renal disorders,
overuse of diuretics), particularly in
cases (e.g. starvation) where a source of energy is required.
4.2 Posology and method of administration
Posology
_Adults, the Elderly and Children_
The dosage depends on the age, weight, clinical and biological
conditions of the patient and concomitant
therapy.
Typical doses of potassium for the prevention of hypokalemia may be up
to 50 mmoles daily and similar
doses may be adequate in mild potassium deficiency. In severe acute
hypokalemia, up to 20 mmoles of
potassium in 500 ml over 2 to 3 hours under ECG control. Patients with
renal impairment should receive
lower doses.
The maximum recommended dose of potassium is 2 to 3 mmol/kg/24h. The
rate should not exceed 10 to
40 mmol/h to avoid hyperkalaemia. For peripheral infusions, potassium
concentration should be less than
60 mmol/l to avoid pain.
The recommended dosage for the treatment of carbohydrates and fluid
depletion is
- for adults : 50